Article Sidebar
Published:
Jul 15, 2024Keywords:
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. http://creativecommons.org/licenses/by-nc-sa/4.0/
The author(s) retain their copyright, which means that authors may use the article for teaching and other non-commercial research purposes without approval from the publisher, provided the journal is acknowledged as the original source.
Disclaimer: Concerted efforts are always made by the Publisher and the Editorial Board to see that no inaccurate or misleading information, opinion or assertion appears in this journal. However, information and opinions appearing in the articles of this journal are the sole responsibility of the author(s) concerned. The Publisher, Editorial Board, their agents or employees, accept no responsibility or liability whatsoever for the consequences of any inaccurate information.
Main Article Content
The effectiveness of therapeutic agents in the treatment of age-related cataract: A systematic review
Abstract
Context: The effectiveness of therapeutic agents in the treatment of age-related cataract has been studied by many authorities and nothing concrete has been documented to encourage further discourse on followups and pharmaceutical trials.
Objective: To investigate the effectiveness of therapeutic agents in the treatment of age-related cataract.
Data Sources: The search engines employed include PUBMED and EBSCO research Databases (Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, E-journals and Open Dissertations).
Study Selection: The key words used were “age-related cataract”, “drug treatment”, “cataract” and “pharmacotherapy”. There was no language restriction. Studies were random controlled trials and quasi experiments that reported relative risks, odds ratios or hazard ratios with 95%CI for their reported results.
Data Extraction: Independent mining of articles by one author applying already defined data fields, including study value pointers.
Data Synthesis: Data was put on a spread sheet and analyzed according to the study parameters of interest.
Results: 90 percent of the studies reported a measure of effects on age-related cataracts in humans and enucleated cataractous human lens nuclei, horses, dogs, and goats, and induced cataracts in rats and rabbits.
Conclusions: Many substances have been researched and shown to inhibit development and progression of age-related cataract in human eyes and in selenite and diabetic cataracts in animal models. It is possible to ameliorate cataract with pharmacotherapy once the right combination of agents is discovered.
